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171 Association between exhaled nitric oxide and disease severity in
cystic ﬁbrosis
S. van Haren Noman, K.M. de Winter-de Groot, M.G. Slieker, C.K. van der Ent.
University Medical Centre, Utrecht, Netherlands
Background: Nitric Oxide (NO) concentrations in exhaled air are generally in-
creased in asthmatic lung disease. In cystic ﬁbrosis (CF), studies show that NO
levels are paradoxically decreased. As NO seems to be important to regulate (anti
viral) host defence, bronchomotor control and inﬂammation, a low NO production
or availability might result in a more severe clinical phenotype of the disease.
Aim of the study was to investigate the association between NO levels and lung
function, infection with P. aeruginosa (PA) and S. aureus and with nutritional status
and genetics.
Methods: In 95 clinically stable children with CF (mean age 12.6 yrs (5.3−17.8),
M/F 48/47) we measured bronchial (bNO) and nasal exhaled NO (nNO). In a
multivariate model association between NO levels and effect parameters were stud-
ied. Effect parameters were available from the annual check-ups of the CF Centre
Utrecht.
Results: In the multivariate analysis low nNO was signiﬁcantly associated with
lower values of FEV1 (p = 0.004) and with severe CFTR mutation (p = 0.016). NNO
was not associated with infection or nutritional status. BNO was signiﬁcantly lower
in PA positive vs PA negative CF patients (median 11.8 vs 7.9 ppb, respectively,
p = 0.03). BNO was not correlated with FEV1, nutritional status or severity of the
CFTR-mutation.
Conclusion: BNO and nNO seem to be associated with the phenotype and genotype
of CF. Patients with more severe phenotype and genotype of CF might lack the
potential beneﬁts of NO.
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Background: Exhaled nitric oxide levels are low in patients with cystic ﬁbrosis
(CF), despite the chronic inﬂammation present in the airways.
Aim: The purpose of this investigation was to study exhaled NO (eNO) concentra-
tion in children and adolescents with CF, and to evaluate the effect of CF genotype,
disease severity, atopic status and respiratory tract infection on this measurement.
Methods: Exhaled NO levels were measured in 36 children and adolescents with
CF and 40 healthy age-matched subjects, using a chemiluminesence analyser,
according to recently published ERS/ATS guidelines. Spirometry (FEV1 and FVC),
CF genotype, bacterial colonization, BMI, white blood cell (WBC) count, C-reactive
protein (CRP), total IgE and Schwachman scores were also recorded.
Results: The mean age of patients was 15.2 years, and the mean FEV1 was 69.3%
(±23.1) predicted. Exhaled NO was signiﬁcantly lower (p< 0.001) in CF patients
(6.4±3.8 ppb) than in control subjects (13.4±5.3 ppb). FEV1 did not correlate with
exhaled NO. No association was observed between eNO values and inﬂammation
markers, Schwachman score, colonization with Pseudomonas aeruginosa, or geno-
type. Exhaled NO correlated signiﬁcantly with total IgE (p< 0.0001, r = 0.864).
Conclusions: Despite the airway inﬂammation that is characteristic of CF, eNO was
reduced. There was no association of eNO with infection status, disease severity
and genotype. Exhaled NO is not a useful measure of inﬂammation in CF lung
disease.
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Objective: Cystic ﬁbrosis (CF) patients may develop hypoxemia during sleep.
Limited information is available on nocturnal oxygen saturation in CF children
with less severe lung disease. The aim of this study was to investigate the degree
of nocturnal oxygen desaturation and predictive factors in CF children with normal
pulmonary function tests (PFT) or mild to moderate lung disease.
Method: Awake resting and post-exercise SpO2 were measured by pulse oximetry.
Each patient had overnight oximetry monitorization at home. Six minute walk test
(6MWT), Shwachman-Kulczycki (S-K), Brasﬁeld and computed tomography (CT)
scores, blood gas analysis and nutritional status of patients were evaluated.
Results: Twenty-four patients (75% female) with a median age of 9.5 years were
included. Nocturnal mean SpO2 did not differ according to the severity of lung
disease based on PFT. However, lowest SpO2 obtained was lower in children
with both mild and moderate lung disease compared to normals (87.4% vs.
91.7%, respectively, p = 0.009). Nocturnal mean SpO2 correlated with S-K (r = 0.80,
p< 0.0001), Brasﬁeld (r = 0.56, p = 0.007) and CT scores (r = −0.82, p< 0.0001)
as well as PaO2 (r = 0.53, p = 0.021), SaO2 (r = 53, p = 0.023), z-score of weight
(r = 0.48, p = 0.20) and height (r = 0.45, p = 0.30), there was no correlation with
6MWT. Multiple linear regression analysis with Backward elimination showed that
nocturnal mean SpO2 was predicted by S-K scores (B = 0.085, p< 0.0001) and CT
scores (B = −0.22, p< 0.0001) while lowest SpO2 was predicted by FEV1 (B= 0.12
p = 0.012).
Conclusions: CF children with normal PFT or mild-to-moderate lung disease may
develop sleep hypoxemia and S-K and CT scores are the best predictive factors.
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The possibility to sustain a spontaneous ventilation can be seen as balance among
neurological mechanisms, respiratory muscles strength and work/load relationship
determined by lung, thoracic and airways mechanics. In CF patients the increased
respiratory work lead to alveolar hypoventilation, hypoxemia and hypercapnia.
Among patients attending our CF Centre a study has been conducted to evaluate
beneﬁts of NIV in patients awaiting lung transplantation. Respiratory mechanics
measures have been conducted with heated pneumotacograph (Fleish #2) con-
nected to a pressure trasductor of ICU-Lab (KleisTek). 179 patients are currently
followed from our CF Centre; median age: 9.26 year. Within this population
33 patients (18.4%) – 17 females, 16 males – have deteriorated pulmonary function
(FEV1> 50%) and they are therefore at risk of organ insufﬁciency. Respiratory
mechanics has been performed on 3 patients awaiting lung transplantation, started
with in NIV. We observed a signiﬁcant decrease of arterial CO2 (p< 0.05), with a
signiﬁcant improvement of acid-base balance (p< 0.05).
The decrease of respiratory work, inspiratory effort in spontaneous breathing and
the increase of the alveolar ventilation explain improvements in gas exchanges.
Respiratory mechanics has evidenced the signiﬁcant improvement (p< 0.05) of
alveolar ventilation (Vti, Vte) and the interruption of mechanism of rapid shallow
breathing (Ti, Ttot) due to pressure support assured by the NIV. The previous
concepts appear even more remarkable if we consider that, by the literature,
PCO2 > 50mmHg is one of main risk factors of death in CF patients awaiting lung
transplantation together with FEV1< 30%, and the need to nutritional interventions.
